ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.140
+0.030 (0.73%)
Mar 9, 2026, 3:20 PM EDT - Market open
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $512.85 million as of March 9, 2026. Its market cap has increased by 217.61% in one year.
Market Cap
512.85M
Enterprise Value
734.31M
1-Year Change
217.61%
Ranking
Category
Stock Price
$4.14
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $512.85M, a decrease of -74.89%. That is a compound annual growth rate of -21.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 527.90M |
| Solid Biosciences | 525.89M |
| Allogene Therapeutics | 516.88M |
| Prothena Corporation | 516.26M |
| Neumora Therapeutics | 513.21M |
| Forte Biosciences | 512.83M |
| CorMedix | 510.67M |
| Invivyd | 507.58M |